Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

294 works between 1988 and 2024

101 - 120 of 294 works

2018

Journal Article

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

Ng, K. L., Del Vecchio, S. J., Samaratunga, H., Morais, C., Rajandram, R., Vesey, D. A., Wood, S. T. and Gobe, G. C. (2018). Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?. Pathology, 50 (5), 504-510. doi: 10.1016/j.pathol.2018.01.007

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

2018

Journal Article

Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction

Koo, Kevin M., Wang, Jing, Richards, Renée S., Farrell, Aine, Yaxley, John W., Samaratunga, Hema, Teloken, Patrick E., Roberts, Matthew J., Coughlin, Geoffrey D., Lavin, Martin F., Mainwaring, Paul N., Wang, Yuling, Gardiner, Robert A. and Trau, Matt (2018). Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction. ACS Nano, 12 (8), 8362-8371. doi: 10.1021/acsnano.8b03698

Design and clinical verification of surface-enhanced Raman spectroscopy diagnostic technology for individual cancer risk prediction

2018

Journal Article

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study

Coughlin, Geoffrey D., Yaxley, John W., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Teloken, Patrick, Dunglison, Nigel, Williams, Scott, Lavin, Martin F. and Gardiner, Robert A. (2018). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. The Lancet Oncology, 19 (8), 1051-1060. doi: 10.1016/S1470-2045(18)30357-7

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study

2018

Journal Article

Utility of Pathology Imagebase for standardisation of prostate cancer grading

Egevad, Lars, Delahunt, Brett, Berney, Daniel M., Bostwick, David G., Cheville, John, Comperat, Eva, Evans, Andrew J., Fine, Samson W., Grignon, David J., Humphrey, Peter A., Hörnblad, Jonas, Iczkowski, Kenneth A., Kench, James G., Kristiansen, Glen, Leite, Katia R.M., Magi-Galluzzi, Cristina, Mckenney, Jesse K., Oxley, Jon, Pan, Chin-Chen, Samaratunga, Hemamali, Srigley, John R., Takahashi, Hiroyuki, True, Lawrence D., Tsuzuki, Toyonori, van der Kwast, Theo, Varma, Murali, Zhou, Ming and Clements, Mark (2018). Utility of Pathology Imagebase for standardisation of prostate cancer grading. Histopathology, 73 (1), 8-18. doi: 10.1111/his.13471

Utility of Pathology Imagebase for standardisation of prostate cancer grading

2018

Journal Article

A novel technique for biobanking of large sections of radical prostatectomy specimens

Lindh, Claes, Delahunt, Brett, Samaratunga, Hemamali, Yaxley, John, Gudjónsdóttir, Jóna, Clements, Mark, Lindberg, Johan and Egevad, Lars (2018). A novel technique for biobanking of large sections of radical prostatectomy specimens. Histopathology, 72 (3), 481-489. doi: 10.1111/his.13386

A novel technique for biobanking of large sections of radical prostatectomy specimens

2018

Conference Publication

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

Yaxely, J. W., Dagher, J., Delahuni, B., Egevad, L., Srigley, J. and Samaratunga, H. (2018). Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques. 71st Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Melbourne Australia, Feb 24-27, 2018. HOBOKEN: WILEY.

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

2018

Journal Article

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

Yaxley, J. W., Dagher, J., Delahunt, B., Egevad, L., Srigley, J. and Samaratunga, H. (2018). Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques. World Journal of Urology, 36 (1), 15-20. doi: 10.1007/s00345-017-2119-0

Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques

2017

Journal Article

Fuhrman grading is inappropriate for papillary renal cell carcinoma

Delahunt, Brett, Egevad, Lars, Srigley, John R. and Samaratunga, Hemamali (2017). Fuhrman grading is inappropriate for papillary renal cell carcinoma. World Journal of Urology, 36 (8), 1335-1336. doi: 10.1007/s00345-017-2153-y

Fuhrman grading is inappropriate for papillary renal cell carcinoma

2017

Journal Article

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations

Egevad, Lars, Delahunt, Brett, Kristiansen, Glen, Samaratunga, Hemamali and Varma, Murali (2017). Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations. Pathology, 50 (1), 60-73. doi: 10.1016/j.pathol.2017.09.008

Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations

2017

Journal Article

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study

Kristiansen, Anna, Drevin, Linda, Delahunt, Brett, Samaratunga, Hemamali, Robinson, David, Franck Lissbrant, Ingela, Stattin, Pär and Egevad, Lars (2017). Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study. Pathology, 49 (7), 715-720. doi: 10.1016/j.pathol.2017.08.008

Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study

2017

Journal Article

The decline of medical publishing: the rise of the pseudo-journal

Delahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2017). The decline of medical publishing: the rise of the pseudo-journal. Pathology, 49 (7), 673-674. doi: 10.1016/j.pathol.2017.08.001

The decline of medical publishing: the rise of the pseudo-journal

2017

Journal Article

Pathology Imagebase-a reference image database for standardization of pathology

Egevad, Lars, Cheville, John, Evans, Andrew J., Hornblad, Jonas, Kench, James G., Kristiansen, Glen, Leite, Katia R. M., Magi-Galluzzi, Cristina, Pan, Chin-Chen, Samaratunga, Hemamali, Srigley, John R., True, Lawrence, Zhou, Ming, Clements, Mark and Delahunt, Brett (2017). Pathology Imagebase-a reference image database for standardization of pathology. Histopathology, 71 (5), 677-685. doi: 10.1111/his.13313

Pathology Imagebase-a reference image database for standardization of pathology

2017

Journal Article

Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells

Kryza, Thomas, Silva, Lakmali M., Bock, Nathalie, Fuhrman-Luck, Ruth, Stephens, Carson, Gao, Jin, Samaratunga, Hema, Lawrence, Mitchell, Hooper, John D., Dong, Ying, Risbridger, Gail and Clements, Judith A. (2017). Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells. Molecular Oncology, 11 (10), 1307-1329. doi: 10.1002/1878-0261.12075

Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells

2017

Journal Article

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

Samaratunga, Hemamali, Delahunt, Brett, Srigley, John R., Yaxley, John, Johannsen, Shulammite, Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, Patterson, Imogen, Nacey, John N. and Egevad, Lars (2017). Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases. Histopathology, 71 (4), 641-647. doi: 10.1111/his.13278

Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases

2017

Journal Article

Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading

Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Srigley, John R, Coughlin, Geoffrey, Dunglinson, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon, Yaxley, John and Samaratunga, Hemamali (2017). Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading. Histopathology, 71 (6), 918-925. doi: 10.1111/his.13311

Clear cell renal cell carcinoma: validation of World Health Organization/ International Society of Urological Pathology grading

2017

Journal Article

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

Yaxley, John W., Lah, Kevin, Yaxley, Julian P., Gardiner, Robert A., Samaratunga, Hema and MacKean, James (2017). Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years. BJU International, 120 (1), 56-60. doi: 10.1111/bju.13659

Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

2017

Conference Publication

PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases

Scott, Susan E., Gianduzzo, Troy, Coughlin, Geoff, Kua, Boon, Parkinson, Rob, Samaratunga, Hemamali and Yaxley, John (2017). PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases. ANZUP Annual Scientific Meeting - The Art & Science of Best Practice, Melbourne, VIC Australia, 16–18 July 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

PIRADS 3 lesions characterised by mp-MRI of the prostate correspond with an intermediate to high risk of clinically significant prostate cancer on whole specimen histopathology - a retrospective review of 42 cases

2017

Journal Article

UICC drops the ball in the 8th edition TNM staging of urological cancers

Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Varma, Murali, Verrill, Clare, Cheville, John, Kristiansen, Glen, Corbishley, Catherine and Berney, Daniel M. (2017). UICC drops the ball in the 8th edition TNM staging of urological cancers. Histopathology, 71 (1), 5-11. doi: 10.1111/his.13200

UICC drops the ball in the 8th edition TNM staging of urological cancers

2017

Journal Article

Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited

Siriwardana, Amila, Thompson, James, van Leeuwen, Pim J., Doig, Shaela, Kalsbeek, Anton, Emmett, Louise, Delprado, Warick, Wong, David, Samaratunga, Hemamali, Haynes, Anne-Maree, Coughlin, Geoff and Stricker, Phillip (2017). Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited. BJU International, 120 (5), 673-681. doi: 10.1111/bju.13919

Initial multicentre experience of 68gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited

2017

Conference Publication

Diagnostic potential of PSMA PET in advanced renal cell carcinoma

Nicholson, C., Joshi, A., Rhee, H., Tham, M., Thomas, P., Blazak, J., Samaratunga, H., Ng, K. L., Globe, G., Vela, I. and Wood, S. (2017). Diagnostic potential of PSMA PET in advanced renal cell carcinoma. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750

Diagnostic potential of PSMA PET in advanced renal cell carcinoma

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au